JPS5942677B2 - 100% free of charge - Google Patents

100% free of charge

Info

Publication number
JPS5942677B2
JPS5942677B2 JP15054775A JP15054775A JPS5942677B2 JP S5942677 B2 JPS5942677 B2 JP S5942677B2 JP 15054775 A JP15054775 A JP 15054775A JP 15054775 A JP15054775 A JP 15054775A JP S5942677 B2 JPS5942677 B2 JP S5942677B2
Authority
JP
Japan
Prior art keywords
formulas
tables
solution
hours
mathematical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP15054775A
Other languages
Japanese (ja)
Other versions
JPS5277093A (en
Inventor
益男 小泉
育敏 松浦
泰 村上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP15054775A priority Critical patent/JPS5942677B2/en
Publication of JPS5277093A publication Critical patent/JPS5277093A/en
Publication of JPS5942677B2 publication Critical patent/JPS5942677B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は、一般式 □H゛)n(I) (式中Xは水素原子、ハロゲン原子、低級アルキル基ま
たはニトロ基を示し、nは3、4または5の整数を意味
する)で表わされる縮合キナゾリノン誘導体およびその
塩の製法に関するものである。
Detailed Description of the Invention The present invention is based on the general formula □H゛)n(I) (wherein X represents a hydrogen atom, a halogen atom, a lower alkyl group or a nitro group, and n is an integer of 3, 4 or 5) This invention relates to a method for producing a condensed quinazolinone derivative and its salt.

従来、縮合キナゾリノン誘導体の製造方法についてはユ
スツス・リービツヒス・アンナーレン・デル・ヘミー6
23巻166頁1959年(Ju−stusLiebi
gsAnnalemderChmie)およびガゼツタ
ー ・キミカ・イタリアーナ99巻59頁1969年(
Ga22ettaChimicaItalia一na)
およびシェルナール・オツプシチエイ・ヒミイー38巻
2030頁1968年(ZhurnalObshche
iKhimii)およびヘーミツシエ・ベリヒテ68巻
2221頁1953年(ChemischeBeric
hte)等に記載され報告されている。
Conventionally, methods for producing fused quinazolinone derivatives have been described in Justus Liebitz Annaren der Chemie 6.
Volume 23, page 166, 1959 (Ju-stus Liebi
gsAnnalemderChmie) and Gazetteer Chimica Italiana, Vol. 99, p. 59, 1969 (
Ga22ettaChimicaItalia1na)
and Zhurnal Obshche Himii, vol. 38, p. 2030, 1968.
iKhimii) and Chemische Berichte, vol. 68, p. 2221, 1953.
hte) and others.

しかし、これらいずれの方法も反応工程が長く、高温で
加熱処理し、その上収率が低い等欠点があり工業的には
不向であつた。本発明者らは、これらの欠点に鑑み種々
研究した結果、反応温度が低く、高収率でその上反応処
理も簡単で工業的に優れた方法を見出し本発明を完成し
た。
However, all of these methods have drawbacks such as long reaction steps, high-temperature heat treatment, and low yields, and are unsuitable for industrial use. The present inventors conducted various studies in view of these drawbacks, and as a result, they found an industrially excellent method that has a low reaction temperature, high yield, and simple reaction treatment, and completed the present invention.

すなわち本発明は、一般式 °(■) (式中Xは水素原子、ハロゲン原子、低級アルキル基ま
たはニトロ基を示す)で表わされる化合物にチオニルハ
ライドを反応させ、次いで一般式(式中nは3,4また
は5の整数を意味する)で表わされる化合物を反応せし
めることを特徴とする一般式(式中Xおよびnは前記と
同一の意味を示す)で表わされる縮合キナゾリノン誘導
体の製法である。
That is, in the present invention, a compound represented by the general formula ° (■) (wherein X represents a hydrogen atom, a halogen atom, a lower alkyl group, or a nitro group) is reacted with thionyl halide, and then a compound represented by the general formula (wherein n is A method for producing a condensed quinazolinone derivative represented by the general formula (wherein X and n have the same meanings as above), characterized by reacting a compound represented by the formula (meaning an integer of 3, 4 or 5). .

本発明を実施するに際しては、チオニルハライドを無極
性溶媒、例えばベンゼン、トルエン、キシレン、ジクロ
ロメタン、クロロホルム、四塩化炭素等に溶解し、該溶
液に化合物を添加する。
In carrying out the present invention, thionyl halide is dissolved in a nonpolar solvent such as benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, etc., and the compound is added to the solution.

次いで得られた溶液を1〜5時間還流したのち残存する
チオニルハライドおよび溶媒を減圧留去する。得られる
残渣を無極性溶媒に溶解し、次いで化合物を無極性溶媒
に溶解した溶液に2〜20℃好ましくは5〜10℃で1
0〜90分好ましくは10〜40分要して滴下する。次
いで得られた溶液を室温〜50℃で1〜6時間攪拌し析
出する粗結晶を済取し、乾燥したのち有機溶媒、例えば
メタノール、エタノール、アセトン、N,N−ジメチル
ホルムアミド、ジメチルスルホキサイド等あるいはこれ
らの混合溶媒より再結晶すると目的化合物1を得る。ま
た、化合物1は必要に応じ常法により処理して塩酸塩、
臭化水素酸塩、硫酸塩、リン酸塩等の無機酸塩および酢
酸塩、コハク酸塩、マレイン酸塩、クエン酸塩等の有機
酸塩とすることができる。このようにして得られた化合
物ま、文献未記載の新規化合物を含み、抗抑うつ作用、
降圧作用、抗炎症作用等の薬理作用を有し、医薬品とし
て有用である。
The resulting solution is then refluxed for 1 to 5 hours, and then the remaining thionyl halide and solvent are distilled off under reduced pressure. The resulting residue is dissolved in a non-polar solvent, and then added to a solution of the compound in a non-polar solvent at 2-20°C, preferably 5-10°C.
The dropwise addition takes 0 to 90 minutes, preferably 10 to 40 minutes. The resulting solution is then stirred at room temperature to 50°C for 1 to 6 hours to collect the precipitated crude crystals, dried, and then mixed with an organic solvent such as methanol, ethanol, acetone, N,N-dimethylformamide, dimethyl sulfoxide. The target compound 1 is obtained by recrystallization from a mixed solvent or a mixed solvent thereof. In addition, Compound 1 can be treated with a conventional method as necessary to form a hydrochloride.
They can be inorganic acid salts such as hydrobromide, sulfate, phosphate, and organic acid salts such as acetate, succinate, maleate, citrate. The compounds obtained in this way include new compounds not described in the literature, and have antidepressant effects,
It has pharmacological effects such as antihypertensive and anti-inflammatory effects, and is useful as a medicine.

次に実施例を挙げて説明する。Next, an example will be given and explained.

実施例 1 123−トリヒドローJメ[メチル一9H−ラ9 ピロロ〔2,1−b〕−キナゾリン の製法 オン チオニルタロライド79をベンゼン15m1に溶解し、
該溶液に2−アミノ−5−メチル安息香酸39を水冷下
徐々に添加する。
Example 1 Preparation of 123-trihydroJmethyl-9H-la-9pyrrolo[2,1-b]-quinazoline Onthionyltalolide 79 was dissolved in 15 ml of benzene,
2-Amino-5-methylbenzoic acid 39 is gradually added to the solution under water cooling.

次いで該溶液を2時間還流したのち、ベンゼンおよび残
存するチオニルクロライドを減圧留去する。残渣をテト
ラヒドロフラン15m1に溶解し、α−ピロリドン1.
79をテトラヒドロフラン15m1に溶解した溶液に撹
拌下5〜1『Cで20分要して滴下する。次いで得られ
た溶液を室温で5時間攪拌し析出する粗生成物を済取し
乾燥し粗結晶3.8gを得る。この粗結晶を希メタノー
ルより再結晶すると無色針状晶の1,2,3−トリヒド
ローJメ[メチル一9Hピロロ〔2,1−b〕−キナゾリ
ン一9−オンを得る。上記で得られた1,2,3−トリ
ヒドローJ■■ン一9−オンを常法により処理し塩酸塩
を得る。
The solution was then refluxed for 2 hours, and then benzene and remaining thionyl chloride were distilled off under reduced pressure. The residue was dissolved in 15 ml of tetrahydrofuran, and 1.5 ml of α-pyrrolidone was added.
79 in 15 ml of tetrahydrofuran was added dropwise with stirring at 5 to 1°C over 20 minutes. The resulting solution was then stirred at room temperature for 5 hours, and the precipitated crude product was collected and dried to obtain 3.8 g of crude crystals. The crude crystals are recrystallized from dilute methanol to obtain colorless acicular crystals of 1,2,3-trihydro-Me[methyl-9H-pyrrolo[2,1-b]-quinazolin-9-one. The 1,2,3-trihydroJ-9-one obtained above is treated in a conventional manner to obtain the hydrochloride.

融点209〜211にC実施例 2 6789−テトラヒトロー2−ニトロ ツ ラ ラ 11H−ピリド〔2,1−b〕−キナゾリン11−オン
の製法に溶解し、該溶液に2−アミノ−5−ニトロ安息
香酸3.69を水冷下徐々に添加する。
Melting point 209-211 CExample 2 6789-Tetrahytrose 2-nitrotura 11H-pyrido[2,1-b]-quinazolin 11-one is dissolved in the solution and 2-amino-5-nitrobenzoic acid is added to the solution. 3.69 is gradually added under water cooling.

次いで該溶液を3時間還流したのちクロロホルムおよび
残存するチオニルクロライドを減圧留去する。残渣をク
ロロホルム10WLIに溶解し、δ−バレロラクタム2
9をクロロホルム20m1に溶解した溶液に攪拌下5〜
10℃で30分要して滴下する。次いで室温にて4時間
攪拌し、析出する粗生成物を淵取して乾燥し粗結晶を4
.19得る。この粗結晶を希ジメチルスルホキサイドよ
り再結晶すると淡褐色針状晶の6,7,8,9−テトラ
ヒトロー2−ニトロ−11H−ピリド〔2,1−b〕−
キナゾリン一11−オンを得る。実施例 3 678910−ペンタヒトロー2−ニドロー12H−ア
ゼピノ〔2,1−b)−キナゾリン一12−オンの製法
実施例2と同様に処理すると6、7、8、9、10−ペ
ンタヒトロー2−ニトロ12H−アゼピノ〔2,1−b
〕−キナゾリン12−オンを得る。
The solution was then refluxed for 3 hours, and then chloroform and remaining thionyl chloride were distilled off under reduced pressure. Dissolve the residue in 10 WLI of chloroform and dissolve δ-valerolactam 2
9 in 20 ml of chloroform while stirring.
Add dropwise at 10°C over 30 minutes. Next, the mixture was stirred at room temperature for 4 hours, the precipitated crude product was filtered out and dried, and the crude crystals were collected for 4 hours.
.. Get 19. The crude crystals were recrystallized from dilute dimethyl sulfoxide to give light brown needle-like crystals of 6,7,8,9-tetrahytone-2-nitro-11H-pyrido[2,1-b]-
Quinazolin-11-one is obtained. Example 3 Preparation of 678910-pentahytrose-2-nitro-12H-azepino[2,1-b)-quinazolin-112-one When treated in the same manner as in Example 2, 6,7,8,9,10-pentahythro-2-nitro-12H -Azepino [2,1-b
]-quinazolin 12-one is obtained.

実施例 4〜11 実施例1と同様に処理すると、次表に示す化合物を得る
Examples 4 to 11 When treated in the same manner as in Example 1, the compounds shown in the following table are obtained.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ (式中Xは水素原子、ハロゲン原子、低級アルキル基ま
たはニトロ基を示す)で表わされる化合物にチオニルハ
ライドを反応させ、次いで一般式▲数式、化学式、表等
があります▼(式中nは3、4または5の整数を意味す
る)で表わされる化合物を反応せしめることを特徴とす
る一般式▲数式、化学式、表等があります▼ (式中Xおよびnは前記と同一の意味を示す)で表わさ
れる縮合キナゾリノン誘導体の製法。
[Claims] 1. A compound represented by the general formula ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (wherein X represents a hydrogen atom, a halogen atom, a lower alkyl group, or a nitro group) is reacted with thionyl halide, Next, there are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. ▼ general formulas characterized by reacting compounds represented by (n in the formula means an integer of 3, 4, or 5) ▲ mathematical formulas, chemical formulas, tables, etc. There is a method for producing a condensed quinazolinone derivative represented by ▼ (wherein X and n have the same meanings as above).
JP15054775A 1975-12-19 1975-12-19 100% free of charge Expired JPS5942677B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15054775A JPS5942677B2 (en) 1975-12-19 1975-12-19 100% free of charge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15054775A JPS5942677B2 (en) 1975-12-19 1975-12-19 100% free of charge

Publications (2)

Publication Number Publication Date
JPS5277093A JPS5277093A (en) 1977-06-29
JPS5942677B2 true JPS5942677B2 (en) 1984-10-16

Family

ID=15499249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15054775A Expired JPS5942677B2 (en) 1975-12-19 1975-12-19 100% free of charge

Country Status (1)

Country Link
JP (1) JPS5942677B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
US4455312A (en) * 1982-08-19 1984-06-19 Portnyagina Vera A 2-(o-Carboxyphenylamino)-6H-pyrimido(2,1-b)-quinazolone-6 and derivatives thereof, and application as antiphlogistics

Also Published As

Publication number Publication date
JPS5277093A (en) 1977-06-29

Similar Documents

Publication Publication Date Title
JPH0314315B2 (en)
JP2556722B2 (en) Novel sulfonamide compound
JPH02138266A (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidine dione derivative
JPH0141637B2 (en)
JPS6354363A (en) Quinoline derivative
SU858570A3 (en) Method of preparing derivatives of 3-(tetrazol-5-yl)-1-azaxanthone or their salts
JPS5942677B2 (en) 100% free of charge
JPS5829320B2 (en) Spirolactone steroid
JPS6322078A (en) Novel benzo(de)isoquinoline -1, 3- dione and its productuion
US3935221A (en) Substituted fusaric acid derivatives
JPS6031823B2 (en) Method for producing carbazole derivatives
JPS6183163A (en) Antitumoral
JPS6110587A (en) 1-azaxanthone-3-carboxylic acid derivative and preparation thereof
US3557108A (en) Phthalazino-phthalazinediones and process for their manufacture
US4075210A (en) Pyrazolo[1,5-a]pyrido[4,3-d]pyrimidin-9(4H)-one and derivatives thereof
US4302463A (en) 1-Azaxanthone-3-carboxylic acids and their production
JPS63225382A (en) Novel benzoquinone derivative and production thereof
JPH02145572A (en) N-substituted amide
JPS604831B2 (en) Method for producing 4(3H)-quinazolinone derivatives
JPS604176B2 (en) Method for producing 2,3-dihydro-4(1H)-quinazolinone derivative
JPS6026794B2 (en) 2-Aminochromone-3-carboxaldehyde derivative and method for producing the same
JPS6011707B2 (en) 1-Carboxyalkylcarbamoyl-5-fluorouracil derivative and method for producing the same
JPS6019314B2 (en) 2,3,6,7↓-tetrahydro↓-3↓-oxo↓-5H↓-pyridazino[3,4↓-b][1,4]oxazine derivative
JPS6183172A (en) Dibenzo (b,f) (1,5) oxazocine derivative, its preparation, and pharmaceutical containing said derivative as active component
JP2809972B2 (en) Method for producing 5-trifluoromethyluracil